Human papillomaviruses, cell cycle and cervical cancer;Papillomavirus humains, cycle cellulaire et cancer du col de l'uterus

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 29, Issue 1, 2000, Pages 13-20

  Mougin, Ch ^a   Humbey, O ^a   Gay, C ^a   Riethmuller, D ^a  

^a Faculté de Médecine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P105; PROTEIN P53;

CARCINOMA; CELL CYCLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; DISEASE ASSOCIATION; DNA INTEGRATION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE STRUCTURE; GENOTYPE; KERATINOCYTE; MUTATION; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS GENOME; WART VIRUS;

CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, VIRAL; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETINOBLASTOMA PROTEIN; SEROTYPING; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS; VIRAL VACCINES; VIRUS INTEGRATION;

EID: 0034090880     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Morris JDH, Eddleston AL, Crook T. Viral infection and cancer. Lancet 1995; 346: 754-8.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cells leukaemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031-5.
3. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
4. Dürst M, Gissmann L, Ikenberg H, zur Hausen H. A new papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812-5.
5. Chow LT, Broker TR. Papillomavirus DNA replication. Intervirology 1994; 37: 150-8.
6. Fuchs PG, Pfister H. Transcription of papillomavirus genomes. Intervirology 1994; 37: 159-67.
7. Durst M, Kleinheinz A, Holz M, Gissman L. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors. J Gen Virol 1985; 66: 1515-22.
8. Wentzensen N, Ridder R, Klaes R, Woerner S, von Knebel Doeberitz M. Characterization of integration sites of human papillomavirus DNA in dysplastic and neoplastic cervical lesions. In: Charleston: 17th International Papillomavirus Conference, 1999: 189.
9. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-5.
10. Fornace AJJ. Mammalian genes induced by radiation: activation of genes associated with growth control. Annu Rev Genet 1992; 26: 507-23.
11. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM et al. Interaction of the p53-regulated protein GADD45 with proliferating cell nuclear antigen. Science 1994; 266: 1376-80.
12. White E. Life, death and the pursuit of apoptosis. Genes Dev 1996; 10: 461-77.
13. Tsunokawa S, Takebe N, Kasamatsu M, Terada M, Sugimura T. Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer. Proc Natl Acad Sci USA 1986; 83: 2200-3.
14. Yasumoto S, Burkhardt AL, Doninger J, diPaolo JA. Human papillomavirus type 16 DNA-induced malignant transformation of NIH3T3 cells. J Virol 1986; 53: 572-7.
15. Dürst M, Dzalieva-Petrusevska RT, Boukam P, Fusenig NE, Gissmann L. Molecular and cytogenetic analysis of immortalized human keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987; 1: 251-6.
16. Chesters PM, McCance DJ. Human papillomavirus types 6 and 16 in cooperation with Ha-ras transform secondary rat embryo fibroblasts. J Gen Virol 1989; 70: 353-65.
17. Mougin C, Bernard B, Lab M. Biologie des infections à papillomavirus. I. Caractéristiques générales. Ann Biol Clin 1997 ; 55 : 553-6.
18. Bonnez W, da Rin C, Borkhuis C, de Mesy Jensen K, Reichman R, Rose RC. Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse. J Virol 1998; 72: 5256-61.
19. Song S, Liem A, Steward B, Miller JA, Lambert PF. The role of human papillomavirus (HPV) type 16 E6 and E7 oncogenes in carcinogenesis. In: Charleston: 17th International Papillomavirus Conference, 1999: 147.
20. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus type 16 and 18 E6-proteins with p53. Science 1990; 248: 76-9.
21. Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991; 67: 547-56.
22. Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene 1999; 18: 2381-6.
23. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998; 393: 229-34.
24. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-7.
25. Humbey O. Codon 72 polymorphism of p53 in cervical squamous intraepithelial lesions: a study of 93 women. European Research Organization on Genital Infection and Neoplasia, EUROGIN 2000, Paris, 5-9 avril 2000.
26. Hayes VM, Hofstra RMW, Buys CHCM, Hollema H, van der Zee AGJ. Homozygous arginine-72 in wild type p53 and risk cervical cancer. Lancet 1998; 352: 1756.
27. Banks L, Matlashewski G. Biochemical and biological activities of the HPV E5 proteins. In: Lacey C Ed. Papillomavirus reviews: current research on papillomaviruses. Leeds: Leeds University Press 1996: 39-45.
28. Matsukura T, Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions, Int J Cancer 1995; 61: 13-22.
29. Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, Arveux P, Seillès E, Mougin C. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy as determined by Hybrid Capture II and a PCR-based method. Diagn Mol Pathol 1999; 8: 157-164.
30. Cox JT. Clinical role of HPV testing. Obstet Gynecol Clin North Am 1996; 23: 811-51.
31. Gay C, Terzibachian Jj, Andreoletti Jb, Mougin C, Madoz L, Bettinger D, Lassabe C. Management of cervical squamous intraepithelial lesions (in diagnosis, treatment and follow-up). Colposcopy or HPV DNA testing? 10th World Congress of the International Federation for Cervical Pathology and Colposcopy, Buenos Aires, 7-11 novembre 1999.
32. Seillès E, Riethmuller D, Mougin C. Biologie des infections à papillomavirus: V. Perspectives vaccinales. Ann Biol Clin 1999; 57: 517-24.